Foyou Pharma: Dydrogesterone Tablets Obtained Drug Registration Certificate

Zhitong
2025.10.21 08:08
portai
I'm PortAI, I can summarize articles.

According to the Zhitong Finance APP, Foyou Pharma announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as "Zhejiang Aisheng") has received the Drug Registration Certificate for Dydrogesterone Tablets (Specification: 10mg) issued by the National Medical Products Administration, approving the production of this drug. Dydrogesterone is an orally absorbable synthetic progestogen

According to the Zhitong Finance APP, Foyou Pharma (601089.SH) announced that its wholly-owned subsidiary Zhejiang Aisheng Pharmaceutical Co., Ltd. (referred to as "Zhejiang Aisheng") has received the Drug Registration Certificate for Dydrogesterone Tablets (Specification: 10mg) issued by the National Medical Products Administration, approving the production of this drug. Dydrogesterone is an orally absorbable synthetic progestogen

Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.